- Home
- SGRP vs OVID Comparison
SGRP vs OVID Comparison
Compare SGRP & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- OVID
- Stock Information
- Founded
- SGRP 1967
- OVID 2014
- Country
- SGRP United States
- OVID United States
- Employees
- SGRP N/A
- OVID N/A
- Industry
- SGRP Business Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- SGRP Consumer Discretionary
- OVID Health Care
- Exchange
- SGRP Nasdaq
- OVID Nasdaq
- Market Cap
- SGRP 25.2M
- OVID 20.6M
- IPO Year
- SGRP 1996
- OVID 2017
- Fundamental
- Price
- SGRP $1.05
- OVID $0.32
- Analyst Decision
- SGRP
- OVID Strong Buy
- Analyst Count
- SGRP 0
- OVID 6
- Target Price
- SGRP N/A
- OVID $2.78
- AVG Volume (30 Days)
- SGRP 67.6K
- OVID 650.4K
- Earning Date
- SGRP 06-17-2025
- OVID 05-13-2025
- Dividend Yield
- SGRP N/A
- OVID N/A
- EPS Growth
- SGRP N/A
- OVID N/A
- EPS
- SGRP N/A
- OVID N/A
- Revenue
- SGRP $196,814,000.00
- OVID $548,000.00
- Revenue This Year
- SGRP N/A
- OVID N/A
- Revenue Next Year
- SGRP N/A
- OVID $28.16
- P/E Ratio
- SGRP N/A
- OVID N/A
- Revenue Growth
- SGRP N/A
- OVID 15.61
- 52 Week Low
- SGRP $1.00
- OVID $0.24
- 52 Week High
- SGRP $2.48
- OVID $3.31
- Technical
- Relative Strength Index (RSI)
- SGRP 44.49
- OVID 55.40
- Support Level
- SGRP $1.01
- OVID $0.27
- Resistance Level
- SGRP $1.21
- OVID $0.32
- Average True Range (ATR)
- SGRP 0.04
- OVID 0.02
- MACD
- SGRP -0.00
- OVID 0.01
- Stochastic Oscillator
- SGRP 23.81
- OVID 75.23
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.